Cargando…
Pediatric papillary thyroid cancer: current management challenges
Although with a standardized incidence of 0.54 cases per 100,000 persons, differentiated thyroid cancer (DTC) is a rare disease in children and adolescents, it nonetheless concerns ~1.4% of all pediatric malignancies. Furthermore, its incidence is rising. Due to the rarity and long survival of pedia...
Autores principales: | Verburg, Frederik A, Van Santen, Hanneke M, Luster, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207438/ https://www.ncbi.nlm.nih.gov/pubmed/28096684 http://dx.doi.org/10.2147/OTT.S100512 |
Ejemplares similares
-
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
por: Lebbink, Chantal A, et al.
Publicado: (2022) -
The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates: a decision-tree-based analysis
por: Heinzel, Alexander, et al.
Publicado: (2022) -
Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023) -
Using nomograms to predict the presence of papillary thyroid carcinoma
por: van Velsen, Evert F. S., et al.
Publicado: (2023) -
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
por: Verburg, Frederik A., et al.
Publicado: (2019)